Top Markets
#1 Akedo Akedo +61.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.50%
#4 Cross Cross +46.58%
#5 Black Phoenix Black Phoenix +34.22%
#6 Velvet Velvet +31.90%
#7 OVERTAKE OVERTAKE +27.47%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.31%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +14.54%
#10 Movement Movement +13.62%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.

BLCM
Clasificación en acciones #38877
Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage... Bellicum Pharmaceuticals, Inc. (BLCM) operates as a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing innovative cellular immunotherapies. Its primary objective is to combat blood cancers and solid tumors across domestic and global markets. Among its pipeline of experimental therapies are two key GoCAR-T candidates currently undergoing Phase 1/2 clinical evaluations. BPX-601, an autologous therapy, targets solid tumors that exhibit the prostate stem cell antigen. Additionally, BPX-603, a dual-switch GoCAR-T treatment, is being investigated for solid tumors characterized by the human epidermal growth factor receptor 2 (HER2) antigens. The company also features Rivo-cel, an allogeneic T cell therapy designed to improve patient prognoses in cases of leukemias, lymphomas, and various inherited blood disorders. Bellicum maintains strategic partnerships and licensing arrangements with several entities, including Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Established in 2004, the company's corporate headquarters are located in Houston, Texas.
Precio por acción
$0.07475
Última sincronización: 2024-03-04
Capitalización bursátil
$755.60K
Cambio (1 día)
-6.68%
Cambio (1 año)
0.00%
País
US
Comercio Bellicum Pharmaceuticals, Inc. (BLCM)

Categoría

Healthcare
Historial del precio de la acción de Bellicum Pharmaceuticals, Inc. (BLCM)
Precio más alto de cierre: $0.08 el 2024-03-01

Precio más bajo de cierre: $214.46 el 2014-12-01
Historial del precio de la acción de Bellicum Pharmaceuticals, Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -58.98%
2023 -77.47%
2022 -48.69%
2021 -48.79%
2020 -67.81%
2019 -72.37%
2018 -59.58%
2017 -43.00%
2016 -22.19%
2015 -6.78%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.69 30.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $848.55 30.06%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE